SEC Filing Analysis: Aeluma, Inc. (ALMU)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: Aeluma, Inc. has filed its Form 8-K to announce its second-quarter fiscal 2026 financial results, highlighting a strong cash position of $38.6 million and reaffirming its full-year revenue guidance. The filing is a standard, scheduled corporate disclosure.
• Market Impact: The filing itself is a neutral event. Market reaction will be driven by how the reported revenue, net loss, and business updates compare to analyst expectations for a pre-commercialization tech company.

Company Information

Field	Value
Company	Aeluma, Inc.
Ticker Symbol	ALMU
CIK	0001828805
Industry	Semiconductors & Related Devices

Insider Information

Field	Value
Name	Not Applicable
CIK	Not Applicable
Title/Position	Not Applicable
Relationship	Not Applicable

Transaction Details

This Form 8-K is for the announcement of financial results and does not contain any insider transaction data. All transaction-related fields are not applicable.

Financial Impact Assessment

This filing reports on the company's overall financial condition, not a specific transaction. Analysis is based on the furnished press release (Exhibit 99.1).

Q2 Fiscal 2026 Financial Highlights

Metric	Value
Revenue	$1.3 million
GAAP Net Loss	($1.9 million)
GAAP EPS	($0.11)
Cash and Equivalents	$38.6 million
FY2026 Revenue Guidance	$4.0M - $6.0M (Reaffirmed)

Impact Evaluation

• Market Cap Context: With a market capitalization of $270 million, Aeluma is an emerging growth company where operational milestones and cash management are critical. The reported cash balance of $38.6 million represents approximately 14.3% of its market cap, providing a significant runway for its R&D and commercialization efforts.
• Ownership Concentration: Not applicable to this filing.
• Dilution Impact: Not applicable to this filing.
• Significance: The filing is of medium significance as it provides a crucial scheduled update on the company's financial health, progress on key contracts (NASA, RFSUNY), and strategic priorities. It confirms the company is tracking toward its annual revenue goals, primarily driven by R&D contracts.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a scheduled earnings report. The market's reaction will depend on whether the results and guidance meet, exceed, or miss consensus estimates. The reaffirmation of guidance is a neutral to slightly positive signal, suggesting stability in its outlook.

Volume & Sentiment

• Expected Volume Impact: Increased trading volume is expected around the earnings announcement, which is typical for such events.
• Sentiment Indicator: Neutral. The report contains both positive developments (new contracts, strong cash) and negative factors (continued net loss), which is standard for a company at this stage.

Investment Insights

Positive Market Indicators

• Strong Liquidity: Cash and equivalents of $38.6 million provide substantial funding for near-term operations and growth initiatives.
• Contract Wins: Awarded contracts from NASA and RFSUNY validate the company's technology and provide non-dilutive funding.
• Guidance Reaffirmed: Management's confidence in reaffirming its full-year revenue guidance of $4.0M to $6.0M provides a degree of certainty to investors.
• Commercialization Progress: The company noted it has begun taking initial, albeit small, sales orders, marking a key milestone.

Risk Factors

• Operating Loss: The company reported a GAAP net loss of $1.9 million for the quarter, indicating it is still in a cash-burn phase.
• Pre-Commercialization Stage: Revenue is still primarily from R&D contracts, and the transition to large-scale commercial sales remains a future objective with inherent execution risks.

Key Takeaways

1. Financially Sound: Aeluma is well-capitalized to pursue its strategic objectives in the coming year.
2. Validation Through Contracts: Government and research contracts continue to be a key source of revenue and technological validation.
3. Path to Commercialization: The company is making tangible steps toward commercial sales, expanding its team and manufacturing readiness.

Additional Context

Transaction Notes

• Purpose of Filing: This Form 8-K serves to furnish the press release (Exhibit 99.1) announcing the company's financial results for the second quarter ended December 31, 2025, in accordance with Regulation FD.